{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T22:54:49Z","timestamp":1768172089600,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.crad.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T11:16:05Z","timestamp":1506338165000},"page":"158-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"73","author":[{"given":"C.H.","family":"Suh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Shinagare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Westenfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Van den Abbeele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2017.08.004_bib1","unstructured":"Cancer Research UK. Statistics by cancer type. Available at: http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer#heading-Zero, Accessed 7 July 2017."},{"key":"10.1016\/j.crad.2017.08.004_bib2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in Oncology (NCCN Guidelines\u00ae) for prostate cancer V.2.2017. Available at: http:\/\/www.nccn.org. Accessed 7 July 2017."},{"key":"10.1016\/j.crad.2017.08.004_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib4","series-title":"American Joint Committee on cancer staging manual","author":"Edge","year":"2010"},{"key":"10.1016\/j.crad.2017.08.004_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4172\/1948-5956.1000070","article-title":"Update the indicator role of serum PSA level and Gleason score of the biopsy for the presence of bony metastases: bone scan findings in a North African Ethnic group","volume":"3","author":"Abdellatif","year":"2011","journal-title":"J Cancer Sci Ther"},{"key":"10.1016\/j.crad.2017.08.004_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1590\/S1677-55382010000600006","article-title":"Do all patients with newly diagnosed prostate cancer need staging radionuclide bone scan? A retrospective study","volume":"36","author":"Al-Ghazo","year":"2010","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1007163227968","article-title":"The value of serum prostate specific antigen and other parameters in detecting bone metastases in prostate cancer","volume":"31","author":"Ataus","year":"1999","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.crad.2017.08.004_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000091620","article-title":"A study on staging bone scans in newly diagnosed prostate cancer","volume":"76","author":"Ayyathurai","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.crad.2017.08.004_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000475184","article-title":"Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase","volume":"27","author":"Barichello","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib10","first-page":"400","article-title":"Bone scan in initial staging of prostate cancer","volume":"81","author":"Boughattas","year":"2003","journal-title":"Tunis Med"},{"key":"10.1016\/j.crad.2017.08.004_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eururo.2009.12.023","article-title":"When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool","volume":"57","author":"Briganti","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000019850","article-title":"Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate","volume":"35","author":"Bruwer","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-5347(17)38325-8","article-title":"Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters","volume":"145","author":"Chybowski","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00345-012-0880-7","article-title":"When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool","volume":"31","author":"De Nunzio","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0090-4295(96)80016-1","article-title":"Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer","volume":"47","author":"Gleave","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.crad.2017.08.004_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1464-410X.1997.00095.x","article-title":"An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer","volume":"79","author":"Gohji","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1046\/j.1464-410X.1997.00141.x","article-title":"When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer?","volume":"79","author":"Haukaas","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jjco\/hym097","article-title":"Bone scanning\u2014who needs it among patients with newly diagnosed prostate cancer?","volume":"37","author":"Hirobe","year":"2007","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.crad.2017.08.004_bib19","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.7314\/APJCP.2013.14.5.3289","article-title":"Retrospective study of predictors of bone metastasis in prostate cancer cases","volume":"14","author":"Ho","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.crad.2017.08.004_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07357909509024892","article-title":"Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer","volume":"13","author":"Huncharek","year":"1995","journal-title":"Cancer Invest"},{"key":"10.1016\/j.crad.2017.08.004_bib21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1442-2042.2005.01118.x","article-title":"Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan","volume":"12","author":"Ishizuka","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/00006231-200007000-00003","article-title":"Association of prostate-specific antigen levels and patterns of benign and malignant uptake detected. On bone scintigraphy in patients with newly diagnosed prostate carcinoma","volume":"21","author":"Jacobson","year":"2000","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2017.08.004_bib23","first-page":"126","article-title":"Is bone scintigraphy necessary in initial staging of prostate cancer patients?","volume":"14","author":"Jaukovic","year":"2011","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0972-3919.110683","article-title":"Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy","volume":"27","author":"Kamaleshwaran","year":"2012","journal-title":"Indian J Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1464-410X.1997.00121.x","article-title":"Which patients with prostatic carcinoma require a staging bone scan?","volume":"79","author":"Kemp","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/cncr.10340","article-title":"Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan","volume":"94","author":"Kosuda","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2017.08.004_bib27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.urolonc.2009.05.007","article-title":"Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population","volume":"29","author":"Lai","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.crad.2017.08.004_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.urology.2010.07.491","article-title":"Unnecessary imaging for the staging of low-risk prostate cancer is common","volume":"77","author":"Lavery","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.crad.2017.08.004_bib29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0360-3016(00)00785-9","article-title":"Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.crad.2017.08.004_bib30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00003072-199908000-00007","article-title":"The value of a baseline bone scan in patients with newly diagnosed prostate cancer","volume":"24","author":"Lin","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s002590050430","article-title":"Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients","volume":"26","author":"Lorente","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1259\/bjr\/79184355","article-title":"Changing the referral criteria for bone scan in newly diagnosed prostate cancer patients","volume":"85","author":"McArthur","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.crad.2017.08.004_bib33","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/01485010390249971","article-title":"Value of prostate-specific antigen in the staging of Taiwanese patients with newly diagnosed prostate cancer","volume":"49","author":"Meng","year":"2003","journal-title":"Arch Androl"},{"key":"10.1016\/j.crad.2017.08.004_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1464-410X.1992.tb15734.x","article-title":"Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer","volume":"70","author":"Miller","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib35","first-page":"286","article-title":"Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naive patients with prostate cancer","volume":"32","author":"Moslehi","year":"2013","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1016\/j.crad.2017.08.004_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.1993.03500010067033","article-title":"The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer","volume":"269","author":"Oesterling","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.crad.2017.08.004_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1464-410X.2003.04480.x","article-title":"Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital","volume":"92","author":"O'Sullivan","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.crad.2017.08.004_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0974-7796.150479","article-title":"A narrowing range of bone scan in newly diagnosed prostate cancer patients: a retrospective comparative study","volume":"7","author":"Ozgur","year":"2015","journal-title":"Urol Ann"},{"key":"10.1016\/j.crad.2017.08.004_bib39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1745-7262.2008.00427.x","article-title":"When is a bone scan study appropriate in asymptomatic men diagnosed with prostate cancer?","volume":"10","author":"Pal","year":"2008","journal-title":"Asian J Androl"},{"key":"10.1016\/j.crad.2017.08.004_bib40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.urology.2010.12.083","article-title":"Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort","volume":"77","author":"Palvolgyi","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.crad.2017.08.004_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S1677-55382003000200005","article-title":"Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy","volume":"29","author":"Rhoden","year":"2003","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1100\/tsw.2009.113","article-title":"The utilization of Gleason grade as the primary criterion for ordering nuclear bone scan in newly diagnosed prostate cancer patients","volume":"9","author":"Ritenour","year":"2009","journal-title":"Sci World J"},{"key":"10.1016\/j.crad.2017.08.004_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01081514","article-title":"The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer","volume":"22","author":"Rudoni","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/003655999750016041","article-title":"Predictive value of prostate-specific antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer","volume":"33","author":"Rydh","year":"1999","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.crad.2017.08.004_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.urology.2006.02.009","article-title":"Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features","volume":"68","author":"Salonia","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.crad.2017.08.004_bib46","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.7314\/APJCP.2013.14.9.4973","article-title":"Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?","volume":"14","author":"Sanjaya","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.crad.2017.08.004_bib47","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.7314\/APJCP.2014.15.4.1707","article-title":"Feedback on baseline use of staging images is important to improve image overuse with newly diagnosed prostate cancer patients","volume":"15","author":"Sawazaki","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.crad.2017.08.004_bib48","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1259\/bjr.71.851.10434906","article-title":"Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer","volume":"71","author":"Spencer","year":"1998","journal-title":"Br J Radiol"},{"key":"10.1016\/j.crad.2017.08.004_bib49","doi-asserted-by":"crossref","first-page":"888","DOI":"10.5604\/12321966.1129953","article-title":"Prostate cancer in patients from rural and suburban areas\u2014PSA value, Gleason score and presence of metastases in bone scan","volume":"21","author":"Szot","year":"2014","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.crad.2017.08.004_bib50","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/jjco\/hyr118","article-title":"Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng\/ml and Gleason score of <=6 at the initial stage of diagnosis","volume":"41","author":"Tanaka","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.crad.2017.08.004_bib51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000421-199410000-00016","article-title":"Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer?","volume":"17","author":"Vijayakumar","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.crad.2017.08.004_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000368912","article-title":"Is it safe to omit baseline bone scan for newly diagnosed prostate cancer patients?","volume":"94","author":"Wang","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.crad.2017.08.004_bib53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1159\/000019619","article-title":"Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?","volume":"33","author":"Wolff","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1464-410x.2001.02275.x","article-title":"Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase","volume":"88","author":"Wymenga","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.crad.2017.08.004_bib55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s10330-009-0150-3","article-title":"The diagnostic correlations of bone scintigraphy, pathological grade and PSA for metastatic prostate cancers","volume":"8","author":"Yang","year":"2009","journal-title":"Chinese\u2013German J Clin Oncol"},{"key":"10.1016\/j.crad.2017.08.004_bib56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1464-410X.2003.04169.x","article-title":"Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?","volume":"91","author":"Yap","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.crad.2017.08.004_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/RLU.0000000000000291","article-title":"Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer","volume":"39","author":"Zacho","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib58","first-page":"1529","article-title":"Metastasis on bone scan with low prostate specific antigen (<\/=20 ng\/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines?","volume":"12","author":"Zaman","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.crad.2017.08.004_bib59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib60","series-title":"Prostate cancer: diagnosis and management. NICE guideline (CG175)","author":"National Institute for Health and Clinical Excellence","year":"2017"},{"key":"10.1016\/j.crad.2017.08.004_bib61","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.juro.2007.03.003","article-title":"Guideline for the management of clinically localized prostate cancer: 2007 update","volume":"177","author":"Thompson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2017.08.004_bib62","article-title":"Appropriate use criteria for bone scintigraphy in prostate and breast cancer: summary and excerpts","volume":"58","author":"Donohoe","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2017.08.004_bib63","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.crad.2017.08.004_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3348\/kjr.2016.17.1.5","article-title":"Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy","volume":"17","author":"Suh","year":"2016","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.crad.2017.08.004_bib65","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3348\/kjr.2015.16.6.1175","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers \u2014 part I. General guidance and tips","volume":"16","author":"Kim","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.crad.2017.08.004_bib66","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers \u2014 part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.crad.2017.08.004_bib67","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0. The cochrane collaboration. Available at: http:\/\/handbookcochraneorg\/chapter_9\/9_5_2_identifying_and_measuring_heterogeneityhtm Updated March 2011. Accessed 15 August 2015."},{"key":"10.1016\/j.crad.2017.08.004_bib68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.crad.2017.08.004_bib69","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.crad.2017.08.004_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017304385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926017304385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:36:19Z","timestamp":1757867779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926017304385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0009926017304385"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2017.08.004","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}